Delivery Order SPE2DB22D1106-SPE2DB25FEXK1
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ZYNRELEF 200-6 MG/7 ML VIAL 7ML under a Delivery Order contract with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,888.39 firm fixed price award has an ultimate completion date of October 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical running through November 2026, which serves as a primary...
- This is a $1,442.70 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ZYNRELEF 200-6MG/7 1S medical products, with a performance period ending on June 24, 2025. The award is not set-aside and was made on May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $130,920.97 and a completion date of July 10, 2025. The order is for the delivery of a variety of pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics, as well as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, has a ceiling value of $1,997.59 and a completion date of June 5, 2025. It is a firm-fixed-price contract for the delivery of pharmaceutical and medical products, including prescription medications, medical devices, specialty pharmaceuticals, vaccines,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of a variety of pharmaceutical products and medical supplies. The contract has a ceiling value of $1,750.59 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 3, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply a wide range of pharmaceutical and medical products. The contract is a delivery order with a firm fixed price and a ceiling value of $4,135.64. It has an ultimate completion date of June 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the U.S. Defense Logistics Agency (DLA) for medical supplies and pharmaceuticals. The contract has a ceiling value of $1,441.12 and an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,247.80 and an ultimate completion date of May 20, 2025. It is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,136.97 with a completion date of July 16, 2024. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $37,988.72 and an ultimate completion date of June 13, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEXK1Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ZYNRELEF 200-6 MG/7 ML VIAL 7ML pharmaceutical product, with a ceiling value of $1,744.77. The contract is a firm fixed-price delivery order with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order is not set-aside and represents an open competition award to Amerisourcebergen Drug Corp as the prime contractor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/11/25 |